Szukanie zaawansowane
Home
Rejestracja
FAQ
Użytkownicy
Grupy
Galerie
Zaloguj się, by sprawdzić wiadomości
Zaloguj
Forum Strona Główna
Nasz button
Napisz odpowiedź
Użytkownik
Temat
Treść wiadomości
Emotikony
Więcej Ikon
Kolor:
Domyślny
Ciemnoczerwony
Czerwony
Pomarańćzowy
Brązowy
Żółty
Zielony
Oliwkowy
Błękitny
Niebieski
Ciemnoniebieski
Purpurowy
Fioletowy
Biały
Czarny
Rozmiar:
Minimalny
Mały
Normalny
Duży
Ogromny
Zamknij Tagi
Opcje
HTML:
NIE
BBCode
:
TAK
Uśmieszki:
TAK
Wyłącz BBCode w tym poście
Wyłącz Uśmieszki w tym poście
Kod potwierdzający: *
Do góry
Skocz do:
Wybierz forum
FORUM
----------------
Regulamin
Informacje/Ogłoszenia
Pomoc
Propozycje
Zarejestruj sie
Kontakt
Przedstaw się
ZESPÓŁ
----------------
Skład
Newsy
Piosenki
Teksty piosenek
O zespole
Nagrody
Zdjęcia
Video
Zloty
Media
Chat
Koncerty
Archiwum
MODA I URODA
----------------
Zdrowie, diety, odchudzanie
Fryzury i pielęgnacja włosów
Tatuaże i piercing
INNE
----------------
Fani
Hydepark
Nasze zdjecia
Ogłoszenia
Zaproszenia
C-box
Nasz button
Reklama
Wrzuć fotkę na serwer!
Przegląd tematu
<table border="0" cellpadding="0" cellspacing="0" width="100%" class="forumline"> <tr> <td class="cat" width="22%">Autor</td> <td class="cat">Wiadomość</td> </tr> <tr> <td width="22%" align="left" valign="top" class="row1"><span class="name"><a name=""></a><b>23cogn94h55</b></span></td> <td class="row1" height="28" valign="top"><table width="100%" border="0" cellspacing="0" cellpadding="0"> <tr> <td width="100%"><img src="http://picsrv.fora.pl/Avalanche/images/icon_minipost.gif" width="12" height="9" alt="Post" title="Post" border="0" /><span class="postdetails">Wysłany: Pon 2:15, 14 Mar 2011<span class="gen"> </span> Temat postu: PPD Acquires Two Research Organizations in China</span></td> </tr> <tr> <td colspan="2"><hr /></td> </tr> <tr> <td colspan="2"><span class="postbody">PPD Inc. has announced two deals in as many days. <br />The Wilmington-based contract research organization said Wednesday that it has agreed to acquire BioDuro LLC in a move that will expand its drug capabilities in China. <br />BioDuro,<a href="http://www.orbto.com/software-outsourcing/" target="_blank" class="postlink">outsourcing software development</a>, described as a drug discovery outsourcing company, operates a laboratory in Beijing. Most of its 660 employees are based in China,<a href="http://www.orbto.com/business-process-outsourcing/data-entry-outsourcing/" target="_blank" class="postlink">Data processing companies</a>, PPD said. <br />When the deal closes,<a href="http://www.orbto.com/software-outsourcing/quality-assurance-outsourcing/" target="_blank" class="postlink">quality assurance companies</a>, expected in the fourth quarter, PPD will employ nearly 1,000 in China, making it the largest CRO to offer clinical development and discovery services in that country, the company said. <br />PPD and BioDuro will perform research and development services for large pharmaceutical clients from early stage through Phase IV development. <br />PPD cited Barclays Capital as saying biopharmaceutical companies spend $20.2 billion on drug discovery research annually. Of that, $1.6 billion is outsourced now, but that is expected to grow to $5 billion to $10 billion in the next three to five years. <br />The BioDuro deal will position PPD "to be the full-service CRO of choice in China,<a href="http://www.orbto.com/offshore-outsourcing/financial-outsourcing/" target="_blank" class="postlink">Financial outsourcing</a>," CEO David Grange said in a statement. <br />Additionally, PPD recently acquired Excel PharmaStudies, the market leader and one of the largest CROs in China. <br />On Tuesday, PPD said it will collaborate with Janssen Pharmaceutia N.V. to develop and commercialize two compounds, one to treat diarrhea-predominant irritable bowel syndrome and the other to treat complicated skin and skin structure and respiratory infections. <br />Under the agreement, PPD could receive millions of dollars in milestone payments and royalties. <br />PPD said it will advance the compounds through Phase II development. When Phase II is completed, Janssen will have the option to develop and commercialize the compounds. <br />In exchange,<a href="http://www.orbto.com/software-outsourcing/quality-assurance-outsourcing/" target="_blank" class="postlink">quality assurance service</a>, PPD would receive up to $330 million in clinical and sales milestones and royalties on sales of the compounds if they are approved for marketing.</span></td> </tr> </table></td> </tr> <tr> <td colspan="2" height="1" class="spaceRow"><img src="http://picsrv.fora.pl/Avalanche/images/spacer.gif" alt="" width="1" height="1" /></td> </tr> </table>
fora.pl
- załóż własne forum dyskusyjne za darmo
Powered by
phpBB
© 2001, 2002 phpBB Group
Avalanche style by
What Is Real
© 2004
Regulamin